Chongqing Jiheng Pharmaceutical Co., Ltd. (SHE:002742)
China · Delayed Price · Currency is CNY 3.520
-0.040 (-1.12%)
Nov 13, 2026, 3:04 PM CST
SHE:002742 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | - | 114.49 | 88.87 | 91.46 | 117.74 | 180.03 |
Cash & Short-Term Investments | 42.2 | 114.49 | 88.87 | 91.46 | 117.74 | 180.03 |
Cash Growth | -42.37% | 28.83% | -2.83% | -22.32% | -34.60% | -47.92% |
Accounts Receivable | - | 115.47 | 614.8 | 1,047 | 1,185 | 1,427 |
Other Receivables | - | 0.34 | 12.17 | 113.6 | 103.81 | 79.32 |
Receivables | - | 115.82 | 626.97 | 1,161 | 1,289 | 1,506 |
Inventory | - | 157.88 | 229.04 | 258.03 | 268.17 | 278.93 |
Prepaid Expenses | - | - | 2.68 | - | - | - |
Other Current Assets | - | 5.31 | 190.17 | 207.24 | 87.63 | 79.51 |
Total Current Assets | - | 393.5 | 1,138 | 1,717 | 1,762 | 2,045 |
Property, Plant & Equipment | - | 469.8 | 885.36 | 1,167 | 1,277 | 1,323 |
Long-Term Investments | - | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
Goodwill | - | 184.43 | 311.22 | 492.98 | 492.98 | 492.98 |
Other Intangible Assets | - | 132.51 | 244.87 | 420.33 | 450.13 | 448.6 |
Long-Term Deferred Tax Assets | - | 10 | 17.84 | 12.65 | 23.33 | 26.9 |
Long-Term Deferred Charges | - | 5.33 | 14.39 | 9.72 | 13.32 | 17.24 |
Other Long-Term Assets | - | 0.14 | 14.59 | 21.02 | 21.39 | 59.61 |
Total Assets | - | 1,196 | 2,626 | 3,841 | 4,041 | 4,413 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | - | 151.38 | 544.65 | 852.76 | 796.43 | 1,045 |
Accrued Expenses | - | 34.89 | 290.24 | 163.03 | 95.31 | 73.66 |
Short-Term Debt | - | 57.32 | 1,358 | 1,379 | 1,276 | 1,160 |
Current Portion of Long-Term Debt | - | 24.57 | 392.27 | 394.88 | 395.38 | 133.28 |
Current Portion of Leases | - | - | 0.13 | - | - | - |
Current Income Taxes Payable | - | 2.14 | 16.61 | 40.7 | 25.81 | 9.85 |
Current Unearned Revenue | - | 19.15 | 57.24 | 44.02 | 98.93 | 53.46 |
Other Current Liabilities | - | 31.57 | 106.18 | 302.99 | 236.65 | 232.12 |
Total Current Liabilities | - | 321.04 | 2,765 | 3,177 | 2,925 | 2,707 |
Long-Term Debt | - | 444.21 | - | - | - | 268 |
Long-Term Leases | - | - | - | - | - | 3.64 |
Long-Term Unearned Revenue | - | 55.67 | 57.58 | 61.15 | 65.29 | 67.55 |
Other Long-Term Liabilities | - | 135.54 | 32.16 | 45.06 | 59.16 | 53.69 |
Total Liabilities | - | 956.46 | 2,855 | 3,283 | 3,049 | 3,100 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | - | 684.1 | 432 | 432 | 432 | 432 |
Additional Paid-In Capital | - | 679.56 | 254.17 | 254.17 | 254.17 | 254.64 |
Retained Earnings | - | -1,195 | -775.6 | -125.47 | 326.57 | 644.46 |
Comprehensive Income & Other | - | - | -322.38 | -215.41 | -210.43 | -210.26 |
Total Common Equity | 148.24 | 168.38 | -411.81 | 345.29 | 802.31 | 1,121 |
Minority Interest | - | 70.92 | 182.8 | 212.47 | 189.34 | 192.43 |
Shareholders' Equity | 218.57 | 239.3 | -229.01 | 557.76 | 991.65 | 1,313 |
Total Liabilities & Equity | - | 1,196 | 2,626 | 3,841 | 4,041 | 4,413 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 483.47 | 526.1 | 1,750 | 1,774 | 1,672 | 1,565 |
Net Cash (Debt) | -441.27 | -411.61 | -1,662 | -1,682 | -1,554 | -1,385 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.50 | -0.60 | -2.43 | -3.91 | -3.62 | -3.21 |
Filing Date Shares Outstanding | 683.24 | 684.1 | 432 | 432 | 432 | 432 |
Total Common Shares Outstanding | 683.24 | 684.1 | 432 | 432 | 432 | 432 |
Working Capital | - | 72.45 | -1,628 | -1,460 | -1,163 | -662.4 |
Book Value Per Share | 0.22 | 0.25 | -0.95 | 0.80 | 1.86 | 2.59 |
Tangible Book Value | -166.68 | -148.56 | -967.9 | -568.03 | -140.8 | 179.26 |
Tangible Book Value Per Share | -0.24 | -0.22 | -2.24 | -1.31 | -0.33 | 0.41 |
Buildings | - | 381.62 | 865.12 | 881.84 | 792.89 | 788.52 |
Machinery | - | 426.97 | 1,145 | 1,173 | 1,202 | 1,188 |
Construction In Progress | - | 1.31 | 12.68 | 205.56 | 301.58 | 277.64 |